Reactive arthritis, new approaches to treatment

Reactive arthritis, new approaches to treatment

AUTHORS : Khachumova K.G. | Lytkina K.A.

RELEVANT UNIVERSITIES :  Russian State Medical University, Moscow, Russia
YEAR : 2009

 

Reactive arthritis (ReA) make up 10% of patients in rheumatological hospitals [7], and urogenic
arthritis accounts for 50–75% of all ReA. This is due to the prevalence of sexually transmitted diseases
and the increased level of laboratory diagnostics of urogenic infections, which makes it possible to
establish the correct diagnosis.
The term “reactive arthritis” is used to denote aseptic inflammation in the joints that has
developed in close connection with any infection. In this case, the pathogen and its antigens cannot
be detected in the joint cavity [1]. The most significant etiological factor in the development of
urogenic arthritis is currently recognized as chlamydia (chlamidia trachomatis). Another pathogen is
mycoplasma.

 

 DOWNLOAD PDF ENGLISH View

مطالب دیگر

Next Post
Bioresonance therapy – mechanisms of therapeutic effect
Previous Post
Lymphogranulomatosis or Brucellosis?
برای نوشتن دیدگاه باید وارد بشوید.
فهرست